- Home
- ARTL
ARTL
Artelo Biosciences Inc.
as 11-15-2024 4:00pm EST
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | SOLANA BEACH |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $5.50 | AVG Volume (30 days): | 16.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.85 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.00 - $1.75 | Next Earning Date: | 11-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Artelo Biosciences Inc. News
ARTL Breaking Stock News: Dive into ARTL Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium
GlobeNewswire
5 days ago
Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
12 days ago
Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program
GlobeNewswire
a month ago
Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th
GlobeNewswire
2 months ago
Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire
3 months ago
Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
4 months ago
Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor
GlobeNewswire
4 months ago
Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium
Compare ARTL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ARTL Artelo Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.